Adamas Trust Inc. 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock $0.01 par value per share (ADAML)

FairStock Score: 65/100 — STEADY

Key Financials

Strengths

• Strong Piotroski F-Score of 7/9 indicating robust financial health across profitability, leverage, and efficiency metrics
• Solid return on equity of 13.0% above cost of capital
• Healthy net profit margin of 12.9% showing consistent profitability
• Revenue growth of 184.2% demonstrates strong top-line momentum
• Attractive 7.1% dividend yield providing steady income returns

Concerns

• High leverage at 7.65x debt-to-equity increases financial risk and interest expense burden

AI Analysis

Adamas Trust Inc. 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock $0.01 par value per share is a micro-cap real estate company. The business generates $323 million in annual revenue with a 12.9% net margin. From a quality standpoint, Adamas shows solid Piotroski F-Score of 7/9 and adequate 13% ROE. Growth dynamics show revenue growing at 184.2% and profit growth of 270.5%. The 7.1% dividend yield adds an income component for patient holders. Our composite FairStock Score of 65/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Adamas's 184% revenue growth trajectory could accelerate as it captures additional market share in the real estate sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Elevated leverage at 7.7x D/E means rising interest rates or revenue weakness could strain debt covenants and force asset sales at distressed prices. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer